|
Real-time
Euronext Paris
10:25:00 02/11/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 0.0750 EUR | 0.00% |
|
-26.47% | -43.61% |
| 29/10 | IntegraGen SA Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 12/10 | ABL Texcell Diagnostics to Acquire French Biotech Company IntegraGen | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| INTEGRAGEN | Bio Diagnostics & Testing | 0.00% | -26.47% | -43.61% | -50.33% | -93.88% | 6L |  |  | |
- Stock Market
- Stocks
- ALINT Stock
- Charts IntegraGen
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
